Possibly of equal (or greater) relevance is the alignment of Precision Oncology's Regulatory strategy with the FDA requirements outlined in pre-submission meetings and and quality of the subsequent submission dossier?
Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt, page-9
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(1.04%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $124.3K | 2.557M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 7844831 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2767851 | 22 |
View Market Depth
| Last trade - 11.58am 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |